Get started
Author

Don W. Shaffer

Observed names: D Shaffer, D W Shaffer, D. Shaffer, Don Shaffer, Don W Shaffer
Observed institutions: WellStar Health System, Brooke Army Medical Center, Landstuhl Regional Medical Center, The University of Texas at San Antonio Health Science Center, Sarah Cannon, Tennessee Oncology
OpenAlex ID: A5113783543
Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network
2005 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 330
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.
1993 · H Burris, R Irvin, et al. · Journal of Clinical Oncology · 133
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days
1992 · James G Wall, Howard A Burris, et al. · Anti-Cancer Drugs · 112
Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5-FU and Radiation Therapy in Locoregional Esophageal Cancer
2003 · Anthony A. Meluch, F. Anthony Greco, et al. · The Cancer Journal · 104
Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/Carboplatin/Etoposide and Gemcitabine/Irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial
2004 · F. Anthony Greco, Gladys I. Rodriguez, et al. · The Oncologist · 53
PDF
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations
2008 · R. Tait, Don Shaffer, et al. · Thrombosis and Haemostasis · 33
Combination Chemotherapy with Gemcitabine and Vinorelbine in the Treatment of Patients with Relapsed or Refractory Small Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network
2003 · John D. Hainsworth, Howard A. Burris III, et al. · Cancer Investigation · 21
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies.
1993 · D W Shaffer, L S Smith, et al. · PubMed · 16
A Phase II Trial of Preoperative Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin for Patients with Locally Advanced Non–Small-Cell Lung Cancer
2004 · John D. Hainsworth, James R. Gray, et al. · Clinical Lung Cancer · 10
Fine‐needle aspiration biopsy of multiple myeloma in a patient with renal‐cell carcinoma: A case report
1993 · Gary L. Cooper, Don W. Shaffer, et al. · Diagnostic Cytopathology · 8
A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer
1996 · Geoffrey R Weiss, Don W Shaffer, et al. · Anti-Cancer Drugs · 3
Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.
2004 · Mario von Depka, Don Shaffer, et al. · Blood · 1
A Randomized Phase I Trial of Etoposide (vp-16) and Gm-csf for Refractory Solid Cancers
1994 · G R Weiss, D. Shaffer, et al. · Journal of Immunotherapy
Establishing a self-perpetuating American Heart Association/Advanced Cardiac Life Support program in West Germany
1993 · Clarence E. Pearson, Don W. Shaffer · Resuscitation
Establishing a Self-Perpetuating American Heart Association/Advanced Cardiac Life Support Program in West Germany
1991 · Don W. Shaffer, Doug E. Ching, et al. · Military Medicine
Works count: 15
Citation count: 824
H-index: 9
I10-index: 9
Year
Topic
Type